Cleared Traditional

K896635 - VIRAL RESPIRATORY INDIRECT FLUORES. MONO. ANTIBODY (FDA 510(k) Clearance)

Feb 1990
Decision
72d
Days
Class 1
Risk

K896635 is an FDA 510(k) clearance for the VIRAL RESPIRATORY INDIRECT FLUORES. MONO. ANTIBODY. This device is classified as a Antisera, Cf, Influenza Virus A, B, C (Class I - General Controls, product code GNW).

Submitted by Baxter Healthcare Corp (Bellevue, US). The FDA issued a Cleared decision on February 2, 1990, 72 days after receiving the submission on November 22, 1989.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3330.

Submission Details

510(k) Number K896635 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 22, 1989
Decision Date February 02, 1990
Days to Decision 72 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code GNW — Antisera, Cf, Influenza Virus A, B, C
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3330